SCHEMBL10495491

SCHEMBL10495491

CC(C(=O)O)c1ccc(O[SiH2]C(C)(C)C(C)C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 10/20 0.45
PTGS2 P35354 9/20 0.45
AKR1C2 P52895 9/20 0.45
PTGS1 P23219 7/20 0.45
TSHR P16473 2/20 0.45
SLC22A6 Q4U2R8 2/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45
CYP1A2 P05177 1/20 0.45
LMNA P02545 2/20 0.42
CYP2C9 P11712 2/20 0.42
CXCR1 P25024 2/20 0.42
CXCR2 P25025 2/20 0.42
ALB P02768 1/20 0.42
ESR1 P03372 1/20 0.42
ALOX5 P09917 1/20 0.42
RARB P10826 1/20 0.42
ADRB3 P13945 1/20 0.42
NFKB1 P19838 1/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7719268 0.76 RIPK1 (0.38) PTGS1TSHRCYP1A2LMNA
SCHEMBL59197 0.73 PTGS2 (0.74) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL2370631 0.72 PTGS2 (0.71) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL13557324 0.72 PTGS2 (0.57) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL599316 0.72 PTGS2 (0.71) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL350067 0.72 PTGS2 (0.71) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL27579668 0.71 KMT2A (0.60) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL28662721 0.71 PTGS2 (0.69) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL9680427 0.70 PTGS2 (0.50) AKR1C3PTGS2AKR1C2PTGS1TSHR
SCHEMBL9680432 0.70 PTGS2 (0.50) AKR1C3PTGS2AKR1C2PTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4876366-A COENZYME REDUCTASE INHIBITORS MERCK & CO., INC. (US) 1989-10-24 US disclosed
EP-0245990-A2 Antihypercholesterolemic compounds MERCK & CO. INC. (US) 1987-11-19 EP disclosed